{"DataElement":{"publicId":"2802770","version":"1","preferredName":"Cluster of Differentiation Laboratory Procedure Performed Type","preferredDefinition":"A description of the cluster of differentiation laboratory test.","longName":"CD_LP_PF_TYP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2802724","version":"1","preferredName":"Cluster of Differentiation Laboratory Procedure Performed","preferredDefinition":"A designation for cell surface molecules present on leukocytes._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"CD_LP_PF","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2802721","version":"1","preferredName":"Cluster of Differentiation Laboratory Procedure","preferredDefinition":"A designation for cell surface molecules present on leukocytes.:A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.","longName":"C78347:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cluster of Differentiation","conceptCode":"C78347","definition":"Cell surface antigens that are differentially expressed on the surface of cells in both a tissue- and differentiation stage-specific manner. Identification of differentiation antigens can be used to characterize, and isolate, the types of cells in a sample and can identify cells that have undergone differentiation or transformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0D5379-7FC5-711B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"ONEDATA","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0D5379-7FD3-711B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2802759","version":"1","preferredName":"Cluster of Differentiation Type","preferredDefinition":"A designation for cell surface molecules present on leukocytes._Type; a subdivision of a particular kind of thing.","longName":"CD_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CD20","valueDescription":"CD20 ","ValueMeaning":{"publicId":"2802760","version":"1","preferredName":"CD20 ","longName":"2802760","preferredDefinition":"Expressed during B-cell ontogeny (early pre-B-cell to plasma cell) by human CD20 Gene (MS4A Family), 297-aa 33-kDa CD20 Antigen is a phosphorylated cell surface integral membrane protein shown to participate in B-cell proliferation, development, and differentiation into plasma cells. MS4A family proteins share structural similarity, sequence homology, and unique expression patterns among hematopoietic cells and nonlymphoid tissues. MS4A proteins contain 4 highly conserved transmembrane domains, flanked by N- and C-terminal cytoplasmic regions. CD20 may be involved in regulation of B-cell activation and may be regulated by protein kinases. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte Antigen CD20","conceptCode":"C38896","definition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-75DE-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C0CC8E4-75F7-2D77-E044-0003BA3F9857","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"NYCHM","dateModified":"2008-11-19","deletedIndicator":"No"},{"value":"CD3","valueDescription":"CD3 Complex","ValueMeaning":{"publicId":"2802761","version":"1","preferredName":"CD3 Complex","longName":"2802761","preferredDefinition":"Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD3 Complex","conceptCode":"C38897","definition":"A protein complex comprised of one T-cell surface glycoprotein CD3 delta chain (CD3D), one T-cell surface glycoprotein CD3 gamma chain (CD3G) and two T-cell surface glycoprotein CD3 epsilon chains (CD3E). CD3D, CD3G and CD3E are transmembrane proteins with one extracellular immunoglobulin domain and one intracellular ITAM domain. The CD3 complex is a T-cell co-receptor that noncovalently associates with either the disulfide bound heterodimeric alpha/beta T-cell receptor (TCR) or gamma/delta TCR and two copies of the accessory protein, T-cell surface glycoprotein CD3 zeta chain (CD247), which is a transmembrane protein with three ITAM domains. The TCR moiety of the TCR-CD3 complex binds to MHC and processed antigens on antigen presenting cells, which triggers phosphorylation of and cellular propagation of the signal by CD247 and the CD3 complex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-7605-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C0CC8E4-761E-2D77-E044-0003BA3F9857","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"NYCHM","dateModified":"2008-11-19","deletedIndicator":"No"},{"value":"CD4","valueDescription":"CD4 Antigen","ValueMeaning":{"publicId":"2802762","version":"1","preferredName":"CD4 Antigen","longName":"2802762","preferredDefinition":"CD4 Antigen, encoded by the CD4 gene, is a T-cell surface glycoprotein. CD4 has a role in cell-cell interactions and may act in signal transduction. CD4 is a accessory protein for MHC class-II antigen/T-cell receptor interaction and functions to initiate or augment the early phase of T-cell activation. CD4 enhances T-cell sensitivity to antigen and binds to LCK, which phosphorylates CD3-zeta. CD4 Antigen also serves as an HIV receptor, binding directly to the envelope protein gp120 on HIV. (From LocusLink, OMIM and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD4","conceptCode":"C16300","definition":"T-cell surface glycoprotein CD4 (458 aa, ~51 kDa) is encoded by the human CD4 gene. This protein plays a role in antigen recognition and HIV entry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-762C-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C0CC8E4-7645-2D77-E044-0003BA3F9857","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"NYCHM","dateModified":"2008-11-19","deletedIndicator":"No"},{"value":"CD56","valueDescription":"Neural Cell Adhesion Molecule","ValueMeaning":{"publicId":"2802765","version":"1","preferredName":"Neural Cell Adhesion Molecule","longName":"2802765","preferredDefinition":"Cell adhesion molecule involved in a diverse range of contact-mediated interactions among neurons, astrocytes, oligodendrocytes, and myotubes. It is widely but transiently expressed in many tissues early in embryogenesis. Four main isoforms exist, including CD56; (ANTIGENS, CD56); but there are many other variants resulting from alternative splicing and post-translational modifications. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, pp115-119)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neural Cell Adhesion Molecule 1","conceptCode":"C25276","definition":"Neural cell adhesion molecule 1 (761 aa, ~84 kDa) is encoded by the human NCAM1 gene. This protein is involved in the mediation of neuron-neuron adhesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-7653-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C0CC8E4-766C-2D77-E044-0003BA3F9857","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"NYCHM","dateModified":"2008-11-19","deletedIndicator":"No"},{"value":"CD8","valueDescription":"CD8 Antigen, Beta Polypeptide 1","ValueMeaning":{"publicId":"2802768","version":"1","preferredName":"CD8 Antigen, Beta Polypeptide 1","longName":"2802768","preferredDefinition":"suppressor T-lymphocyte marker that functions as a receptor for MHC class I antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD8 Beta Chain","conceptCode":"C17441","definition":"T-cell surface glycoprotein CD8 beta chain (210 aa, ~24 kDa) is encoded by the human CD8B gene. This protein plays a role in T-cell cytotoxicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-767A-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C0CC8E4-7693-2D77-E044-0003BA3F9857","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"NYCHM","dateModified":"2008-11-19","deletedIndicator":"No"},{"value":"CD4+ / CD45RO+ (memory T cells)","valueDescription":"CD4 Positive Memory T-Lymphocyte","ValueMeaning":{"publicId":"3252703","version":"1","preferredName":"CD4 Positive Memory T-Lymphocyte","longName":"3252703","preferredDefinition":"A mature T lymphocyte that has encountered antigen at a previous time and is primed to react strongly during its next encounter with that antigen. These cells can be identified by the presence of both the CD4 and CD45RO molecules on their surface.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD4 Positive Memory T-Lymphocyte","conceptCode":"C97349","definition":"A mature T lymphocyte that has encountered antigen at a previous time and is primed to react strongly during its next encounter with that antigen. These cells can be identified by the presence of both the CD4 and CD45RO molecules on their surface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7E1ED79-B6D0-3062-E040-BB89AD431105","latestVersionIndicator":"Yes","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7E1ED79-B6E9-3062-E040-BB89AD431105","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA","dateModified":"2011-07-12","deletedIndicator":"No"},{"value":"CD4+ / CD45RA+ (naive T cells)","valueDescription":"CD4 Positive Naive T-Lymphocyte","ValueMeaning":{"publicId":"3252704","version":"1","preferredName":"CD4 Positive Naive T-Lymphocyte","longName":"3252704","preferredDefinition":"A T lymphocyte that has differentiated in the bone marrow, undergone central selection in the thymus, but has not encountered its cognate antigen in the peripheral circulation. These cells can be identified by presence of both the CD4 and CD45RA molecules on their surface.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD4 Positive Naive T-Lymphocyte","conceptCode":"C97350","definition":"A T lymphocyte that has differentiated in the bone marrow, undergone central selection in the thymus, but has not encountered its cognate antigen in the peripheral circulation. These cells can be identified by presence of both the CD4 and CD45RA molecules on their surface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7E1ED79-B6F5-3062-E040-BB89AD431105","latestVersionIndicator":"Yes","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7E1ED79-B70E-3062-E040-BB89AD431105","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA","dateModified":"2011-07-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2802758","version":"1","preferredName":"Cluster of Differentiation Type","preferredDefinition":"A designation for cell surface molecules present on leukocytes.:Type; a subdivision of a particular kind of thing.","longName":"C78347:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cluster of Differentiation","conceptCode":"C78347","definition":"Cell surface antigens that are differentially expressed on the surface of cells in both a tissue- and differentiation stage-specific manner. Identification of differentiation antigens can be used to characterize, and isolate, the types of cells in a sample and can identify cells that have undergone differentiation or transformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-75B8-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"ONEDATA","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CC8E4-75C9-2D77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeDescription":"Added 2 PV on 7/12/11. AK 7/12/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"3234637","version":"1","longName":"2131r2: Immune Deficiencies Post-HSCT Data","context":"NHLBI"},{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify cluster of differenti","type":"Preferred Question Text","description":"Specify cluster of differentiation type:","url":null,"context":"NHLBI"},{"name":"What is the cluster of differentiation type:","type":"Alternate Question Text","description":"What is the cluster of differentiation type:","url":null,"context":"NHLBI"},{"name":"What is the lymphocyte analysis type?","type":"Alternate Question Text","description":"What is the lymphocyte analysis type?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C0CDB18-95AF-3142-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-19","modifiedBy":"KUMMEROA","dateModified":"2014-10-26","changeDescription":"Updated CDE with added PVs. AK 7/12/11 Added CSIs 2031/2131r2. AK 12/7/12  Added AQT 4/30/14 SLS. Added human readable def. System generated def displayed as alt def. No version needed. AK 10/26/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}